Literature DB >> 24192979

Diffusion-weighted MRI, 11C-choline PET and 18F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma.

Joe H Chang1, Daryl Lim Joon, Sze Ting Lee, Chee-Yan Hiew, Stephen Esler, Sylvia J Gong, Morikatsu Wada, David Clouston, Richard O'Sullivan, Yin P Goh, Henri Tochon-Danguy, J Gordon Chan, Damien Bolton, Andrew M Scott, Vincent Khoo, Ian D Davis.   

Abstract

OBJECTIVES: To evaluate the accuracy of transrectal ultrasound-guided (TRUS) biopsy, diffusion-weighted (DW) magnetic resonance imaging (MRI), (11)C-choline (CHOL) positron emission tomography (PET), and (18)F-fluorodeoxyglucose (FDG) PET in predicting the prostatectomy Gleason risk (GR).
METHODS: The study included 21 patients who underwent TRUS biopsy and multi-technique imaging before radical prostatectomy. Values from five different tests (TRUS biopsy, DW MRI, CHOL PET, FDG PET, and combined DW MRI/CHOL PET) were correlated with the prostatectomy GR using Spearman's ρ. Tests that were found to have significant correlations were used to classify patients into GR groups.
RESULTS: The following tests had significant correlations with prostatectomy GR: TRUS biopsy (ρ = 0.617, P = 0.003), DW MRI (ρ = -0.601, P = 0.004), and combined DW MRI/CHOL PET (ρ = -0.623, P = 0.003). CHOL PET alone and FDG PET only had weak correlations. The correct GR classification rates were 67% with TRUS biopsy, 67% with DW MRI, and 76% with combined DW MRI/CHOL PET.
CONCLUSIONS: DW MRI and combined DW MRI/CHOL PET have significant correlations and high rates of correct classification of the prostatectomy GR, the strength and accuracy of which are comparable with TRUS biopsy. KEY POINTS: • Accurate determination of the Gleason score is essential for prostate cancer management. • DW MRI ± CHOL PET correlated significantly with prostatectomy Gleason score. • These correlations are similar to that between TRUS biopsy and prostatectomy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24192979     DOI: 10.1007/s00330-013-3045-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  26 in total

1.  FDG PET in Prostate Cancer.

Authors:  Hossein Jadvar
Journal:  PET Clin       Date:  2009-04-01

Review 2.  The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.

Authors:  Jonathan I Epstein; William C Allsbrook; Mahul B Amin; Lars L Egevad
Journal:  Am J Surg Pathol       Date:  2005-09       Impact factor: 6.394

3.  Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla.

Authors:  Peter Gibbs; Gary P Liney; Martin D Pickles; Bashar Zelhof; Greta Rodrigues; Lindsay W Turnbull
Journal:  Invest Radiol       Date:  2009-09       Impact factor: 6.016

4.  NCCN clinical practice guidelines in oncology: prostate cancer.

Authors:  James Mohler; Robert R Bahnson; Barry Boston; J Erik Busby; Anthony D'Amico; James A Eastham; Charles A Enke; Daniel George; Eric Mark Horwitz; Robert P Huben; Philip Kantoff; Mark Kawachi; Michael Kuettel; Paul H Lange; Gary Macvicar; Elizabeth R Plimack; Julio M Pow-Sang; Mack Roach; Eric Rohren; Bruce J Roth; Dennis C Shrieve; Matthew R Smith; Sandy Srinivas; Przemyslaw Twardowski; Patrick C Walsh
Journal:  J Natl Compr Canc Netw       Date:  2010-02       Impact factor: 11.908

5.  Histopathological correlation of (11)C-choline PET scans for target volume definition in radical prostate radiotherapy.

Authors:  Joe H Chang; Daryl Lim Joon; Sze Ting Lee; Sylvia J Gong; Andrew M Scott; Ian D Davis; David Clouston; Damien Bolton; Christopher S Hamilton; Vincent Khoo
Journal:  Radiother Oncol       Date:  2011-05-18       Impact factor: 6.280

6.  Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.

Authors:  Aytekin Oto; Cheng Yang; Arda Kayhan; Maria Tretiakova; Tatjana Antic; Christine Schmid-Tannwald; Scott Eggener; Gregory S Karczmar; Walter M Stadler
Journal:  AJR Am J Roentgenol       Date:  2011-12       Impact factor: 3.959

7.  Transrectal ultrasonotomography of the prostate.

Authors:  H Watanabe; D Igari; Y Tanahashi; K Harada; M Saitoh
Journal:  J Urol       Date:  1975-11       Impact factor: 7.450

8.  Prostate MRI: diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason Grades than TRUS-guided biopsies in peripheral zone tumours.

Authors:  Leonardo Kayat Bittencourt; Jelle O Barentsz; Luiz Carlos Duarte de Miranda; Emerson Leandro Gasparetto
Journal:  Eur Radiol       Date:  2011-09-14       Impact factor: 5.315

9.  Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?

Authors:  Baris Turkbey; Vijay P Shah; Yuxi Pang; Marcelino Bernardo; Sheng Xu; Jochen Kruecker; Julia Locklin; Angelo A Baccala; Ardeshir R Rastinehad; Maria J Merino; Joanna H Shih; Bradford J Wood; Peter A Pinto; Peter L Choyke
Journal:  Radiology       Date:  2010-12-21       Impact factor: 11.105

10.  Classification of prostatic carcinomas.

Authors:  D F Gleason
Journal:  Cancer Chemother Rep       Date:  1966-03
View more
  5 in total

1.  Usefulness of MRI-assisted metabolic volumetric parameters provided by simultaneous (18)F-fluorocholine PET/MRI for primary prostate cancer characterization.

Authors:  Yong-Il Kim; Gi Jeong Cheon; Jin Chul Paeng; Jeong Yeon Cho; Cheol Kwak; Keon Wook Kang; June-Key Chung; Euishin Edmund Kim; Dong Soo Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-03-11       Impact factor: 9.236

Review 2.  PET/MRI in Oncological Imaging: State of the Art.

Authors:  Usman Bashir; Andrew Mallia; James Stirling; John Joemon; Jane MacKewn; Geoff Charles-Edwards; Vicky Goh; Gary J Cook
Journal:  Diagnostics (Basel)       Date:  2015-07-21

3.  Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US.

Authors:  Natalia Arteaga-Marrero; Cecilie Brekke Rygh; Jose F Mainou-Gomez; Tom C H Adamsen; Nataliya Lutay; Rolf K Reed; Dag R Olsen
Journal:  J Transl Med       Date:  2015-12-18       Impact factor: 5.531

4.  Assessing the validity of Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) scoring system in diagnosis of peripheral zone prostate cancer.

Authors:  Eman F Dola; Osama L Nakhla; Eman A Sh Genidi
Journal:  Eur J Radiol Open       Date:  2017-03-21

5.  Clinical significance of prostate 18F-labelled fluorodeoxyglucose uptake on positron emission tomography/computed tomography: A five-year review.

Authors:  Madhurima R Chetan; Tristan Barrett; Ferdia A Gallagher
Journal:  World J Radiol       Date:  2017-09-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.